首页 > 最新文献

Radiation research. Supplement最新文献

英文 中文
Potential for low-LET charged-particle radiation therapy in cancer. 低let带电粒子放射治疗癌症的潜力。
Pub Date : 1985-11-01 DOI: 10.2307/3576661
M. Goitein, H. Suit, E. Gragoudas, A. Koehler, R. Wilson
The current and likely future status of low-LET charged-particle therapy of cancer is reviewed with regard to both physical and clinical aspects. We conclude that such therapy has reached the stage at which clinical implementation is practical and that a broader program is needed if the clinical advantages of improved dose distributions are to be determined.
从物理和临床两方面综述了低let电荷粒子治疗癌症的现状和可能的未来状况。我们的结论是,这种疗法已达到临床实施的阶段,如果要确定改善剂量分布的临床优势,则需要更广泛的计划。
{"title":"Potential for low-LET charged-particle radiation therapy in cancer.","authors":"M. Goitein, H. Suit, E. Gragoudas, A. Koehler, R. Wilson","doi":"10.2307/3576661","DOIUrl":"https://doi.org/10.2307/3576661","url":null,"abstract":"The current and likely future status of low-LET charged-particle therapy of cancer is reviewed with regard to both physical and clinical aspects. We conclude that such therapy has reached the stage at which clinical implementation is practical and that a broader program is needed if the clinical advantages of improved dose distributions are to be determined.","PeriodicalId":77888,"journal":{"name":"Radiation research. Supplement","volume":"44 1","pages":"S297-309"},"PeriodicalIF":0.0,"publicationDate":"1985-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76322344","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Predictors of tumor response to radiotherapy. 肿瘤对放疗反应的预测因素。
Pub Date : 1985-11-01 DOI: 10.2307/3576660
W. Brock, M. Maor, L. Peters
The present method for predicting the radiocurability of individual human tumors is based upon considerations of tumor size, site, histological type and grade, and host factors such as sex and age. Small tumors located such that normal tissues do not seriously limit total dose and those with "favorable" histology are more radiocurable than large tumors located over a critical normal tissue. However, the precision of prognosis based upon those features is relatively low. The need for other parameters for more accurate predictability is greater than ever because of the existence of different radiation modalities, including neutrons, and the development of a broad range of chemotherapeutic drugs that can be used alone or in combination with radiation and surgery. In this laboratory we are testing the micronucleus (MN) assay for measuring the relative biological effectiveness of high- and low-LET irradiations in mouse tumors and a new primary human tumor cell culture system for making direct measurements of tumor cell radiosensitivity. The potential usefulness of these two systems in predicting human tumor response to radiotherapy is discussed.
目前预测个体人类肿瘤放射治愈性的方法是基于肿瘤大小、部位、组织学类型和分级以及宿主因素(如性别和年龄)的考虑。位于正常组织的小肿瘤不会严重限制总剂量,而那些具有“有利”组织学的肿瘤比位于关键正常组织的大肿瘤更容易放射治愈。然而,基于这些特征的预后精度相对较低。由于包括中子在内的不同放射方式的存在,以及广泛的化疗药物的发展,可以单独使用或与放射和手术联合使用,因此比以往任何时候都更需要其他更准确的可预测性参数。在这个实验室里,我们正在测试微核(MN)测定法,用于测量高let和低let照射在小鼠肿瘤中的相对生物学有效性,以及一种新的原代人肿瘤细胞培养系统,用于直接测量肿瘤细胞的放射敏感性。讨论了这两种系统在预测人类肿瘤对放疗反应方面的潜在用途。
{"title":"Predictors of tumor response to radiotherapy.","authors":"W. Brock, M. Maor, L. Peters","doi":"10.2307/3576660","DOIUrl":"https://doi.org/10.2307/3576660","url":null,"abstract":"The present method for predicting the radiocurability of individual human tumors is based upon considerations of tumor size, site, histological type and grade, and host factors such as sex and age. Small tumors located such that normal tissues do not seriously limit total dose and those with \"favorable\" histology are more radiocurable than large tumors located over a critical normal tissue. However, the precision of prognosis based upon those features is relatively low. The need for other parameters for more accurate predictability is greater than ever because of the existence of different radiation modalities, including neutrons, and the development of a broad range of chemotherapeutic drugs that can be used alone or in combination with radiation and surgery. In this laboratory we are testing the micronucleus (MN) assay for measuring the relative biological effectiveness of high- and low-LET irradiations in mouse tumors and a new primary human tumor cell culture system for making direct measurements of tumor cell radiosensitivity. The potential usefulness of these two systems in predicting human tumor response to radiotherapy is discussed.","PeriodicalId":77888,"journal":{"name":"Radiation research. Supplement","volume":"10 1","pages":"S290-6"},"PeriodicalIF":0.0,"publicationDate":"1985-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81524518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 32
Progress in low-LET heavy particle therapy: intracranial and paracranial tumors and uveal melanomas. 低let重粒子治疗的进展:颅内和颅旁肿瘤和葡萄膜黑色素瘤。
Pub Date : 1985-11-01 DOI: 10.2307/3576651
Mary Austin-Seymour, J. Munzenrider, M. Goitein, R. Gentry, E. Gragoudas, Andreas Koehler, P. Mcnulty, Estelle Osborne, D. Ryugo, Joanna Seddon, M. Urie, Lynn Verhey, H. Suit
The Harvard Cyclotron Laboratory in collaboration with the Department of Radiation Medicine of the Massachusetts General Hospital and the Retina Service of the Massachusetts Eye and Ear Infirmary provides low-LET heavy particle therapy with 160 MeV protons. The improved dose distribution of protons results from their physical characteristics. A total of 965 patients have been treated as of December 31, 1984. Dose is expressed in units of cobalt gray equivalent (CGE) which is the dose in Gy multiplied by the RBE (1.1) for modulated protons relative to 60Co radiation. Sixty-seven patients with chordomas or low-grade chondrosarcomas of the base of skull or cervical spine have received proton treatment. Forty-three of these patients have been followed for at least 8 months with a median follow-up of 27 months. The median dose is 69 CGE. The 3-year actuarial local control rate is 89%. Seven patients with gliomas, eight with craniopharyngiomas, and six with meningiomas have also received proton radiation treatments. A total of 615 patients with uveal melanomas have received a median dose of 70 CGE in five fractions. Tumor regression has been seen in 94% with 66% having vision of 20/100 or better.
哈佛回旋加速器实验室与马萨诸塞州总医院放射医学部和马萨诸塞州眼耳医院视网膜服务中心合作,提供160 MeV质子的低let重粒子治疗。质子剂量分布的改善是由它们的物理特性决定的。截至1984年12月31日,共有965名患者接受了治疗。剂量以钴灰当量(CGE)为单位表示,CGE是以Gy为单位的剂量乘以相对于60Co辐射的调制质子的RBE(1.1)。67例颅底或颈椎脊索瘤或低度软骨肉瘤接受质子治疗。43例患者随访时间至少为8个月,中位随访时间为27个月。中位剂量为69 CGE。3年精算局部控制率为89%。7名胶质瘤患者、8名颅咽管瘤患者和6名脑膜瘤患者也接受了质子放射治疗。共有615名葡萄膜黑色素瘤患者接受了中位剂量70 CGE的5次治疗。94%的患者肿瘤消退,66%的患者视力为20/100或更好。
{"title":"Progress in low-LET heavy particle therapy: intracranial and paracranial tumors and uveal melanomas.","authors":"Mary Austin-Seymour, J. Munzenrider, M. Goitein, R. Gentry, E. Gragoudas, Andreas Koehler, P. Mcnulty, Estelle Osborne, D. Ryugo, Joanna Seddon, M. Urie, Lynn Verhey, H. Suit","doi":"10.2307/3576651","DOIUrl":"https://doi.org/10.2307/3576651","url":null,"abstract":"The Harvard Cyclotron Laboratory in collaboration with the Department of Radiation Medicine of the Massachusetts General Hospital and the Retina Service of the Massachusetts Eye and Ear Infirmary provides low-LET heavy particle therapy with 160 MeV protons. The improved dose distribution of protons results from their physical characteristics. A total of 965 patients have been treated as of December 31, 1984. Dose is expressed in units of cobalt gray equivalent (CGE) which is the dose in Gy multiplied by the RBE (1.1) for modulated protons relative to 60Co radiation. Sixty-seven patients with chordomas or low-grade chondrosarcomas of the base of skull or cervical spine have received proton treatment. Forty-three of these patients have been followed for at least 8 months with a median follow-up of 27 months. The median dose is 69 CGE. The 3-year actuarial local control rate is 89%. Seven patients with gliomas, eight with craniopharyngiomas, and six with meningiomas have also received proton radiation treatments. A total of 615 patients with uveal melanomas have received a median dose of 70 CGE in five fractions. Tumor regression has been seen in 94% with 66% having vision of 20/100 or better.","PeriodicalId":77888,"journal":{"name":"Radiation research. Supplement","volume":"220 1","pages":"S219-26"},"PeriodicalIF":0.0,"publicationDate":"1985-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81254149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 81
Cellular fast-mixing techniques: possible applications with particle beams. 细胞快速混合技术:粒子束的可能应用。
Pub Date : 1985-11-01 DOI: 10.2307/3576630
G. E. Adams
In the past cellular fast-mixing techniques have been used to investigate the time resolution of radiation processes that lead to modification of radiation response in bacterial and mammalian cellular systems. So far, published studies have been confined to effects with low-LET electron beams. The brief for this paper was to discuss where, and under what conditions, such a technique could be used to advantage with high-LET particle beams. Criteria for the experimental design, including conditions of flow rate, dose rate, and mixing times, are discussed. Radiobiological problems appropriate for applications of fast-particle beams are also discussed. These include studies to reveal possible multicomponents in cellular sensitization by oxygen and electron-affinic radiation sensitizers, studies designed to assist in the resolution of direct and indirect effects, and resolution of intracellular DNA damage.
在过去,细胞快速混合技术已被用于研究导致细菌和哺乳动物细胞系统中辐射响应改变的辐射过程的时间分辨率。到目前为止,已发表的研究仅限于低let电子束的效应。本文的主旨是讨论在什么地方,在什么条件下,这种技术可以用于高let粒子束的优势。讨论了实验设计的准则,包括流速、剂量率和混合时间的条件。本文还讨论了适用于快粒子束应用的放射生物学问题。这些研究包括揭示氧和电子亲合辐射致敏剂在细胞致敏过程中可能存在的多组分的研究,旨在帮助解决直接和间接影响的研究,以及解决细胞内DNA损伤的研究。
{"title":"Cellular fast-mixing techniques: possible applications with particle beams.","authors":"G. E. Adams","doi":"10.2307/3576630","DOIUrl":"https://doi.org/10.2307/3576630","url":null,"abstract":"In the past cellular fast-mixing techniques have been used to investigate the time resolution of radiation processes that lead to modification of radiation response in bacterial and mammalian cellular systems. So far, published studies have been confined to effects with low-LET electron beams. The brief for this paper was to discuss where, and under what conditions, such a technique could be used to advantage with high-LET particle beams. Criteria for the experimental design, including conditions of flow rate, dose rate, and mixing times, are discussed. Radiobiological problems appropriate for applications of fast-particle beams are also discussed. These include studies to reveal possible multicomponents in cellular sensitization by oxygen and electron-affinic radiation sensitizers, studies designed to assist in the resolution of direct and indirect effects, and resolution of intracellular DNA damage.","PeriodicalId":77888,"journal":{"name":"Radiation research. Supplement","volume":"72 1","pages":"S40-6"},"PeriodicalIF":0.0,"publicationDate":"1985-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86904858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Heavy charged-particle Bragg peak radiosurgery for intracranial vascular disorders. 重电荷粒子Bragg峰放射治疗颅内血管疾病。
Pub Date : 1985-01-01
J I Fabrikant, J T Lyman, K A Frankel

The program at Donner Pavilion has applied nuclear medicine research to the diagnosis and radiosurgical treatment of life-threatening intracranial vascular disorders that affect approximately one million Americans. Stereotactic heavy-ion Bragg peak radiosurgery, using narrow beams of heavy ions (helium), demonstrates superior biological and physical characteristics in brain over X and gamma rays and protons, viz., improved dose distribution in the Bragg peak, sharp lateral and distal borders, and less multiple scattering and range straggling for the same residual range in CNS tissue. Examination of CNS tissue response and alteration of cerebral blood-flow dynamics related to heavy-ion Bragg peak radiosurgery is being undertaken using three-dimensional treatment planning and quantitative imaging utilizing cerebral angiography, computerized tomography (CT), magnetic resonance imaging (MRI), cine-CT, xenon X-ray CT, and positron emission tomography (PET). Also under examination are the physical properties of narrow heavy-ion beams for improving methods of dose delivery and dose distribution and for establishing clinical RBE/LET and dose-response relationships for human CNS tissues. Based on the evaluation and treatment with stereotactically directed narrow beams of heavy ions of over 130 patients, with cerebral angiography and CT scanning, and with MRI and radioisotope scanning of selected patients, plus extensive clinical and neuroradiological follow-up, it appears that heavy-ion radiosurgery obliterates intracranial arteriovenous malformations or protects against rebleeding with reduced morbidity and mortality.

唐纳馆的项目将核医学研究应用于危及生命的颅内血管疾病的诊断和放射外科治疗,这些疾病影响着大约100万美国人。立体定向重离子Bragg峰放射外科,使用窄束重离子(氦),在X射线和伽马射线和质子中表现出优越的脑生物学和物理特性,即改善了Bragg峰的剂量分布,侧面和远端边界清晰,减少了CNS组织相同残余范围内的多次散射和范围偏移。利用三维治疗计划和定量成像技术,利用脑血管造影、计算机断层扫描(CT)、磁共振成像(MRI)、电影CT、氙x射线CT和正电子发射断层扫描(PET),对重离子布拉格峰放射手术相关的中枢神经系统组织反应和脑血流动力学改变进行检查。窄重离子束的物理特性也在研究中,以改进剂量传递和剂量分配方法,并建立临床RBE/LET和人体中枢神经系统组织的剂量-反应关系。通过对130多例患者的立体定向窄束重离子的评价和治疗,脑血管造影和CT扫描,以及部分患者的MRI和放射性同位素扫描,以及广泛的临床和神经放射学随访,我们认为重离子放射手术可以消除颅内动静脉畸形或防止再出血,降低发病率和死亡率。
{"title":"Heavy charged-particle Bragg peak radiosurgery for intracranial vascular disorders.","authors":"J I Fabrikant,&nbsp;J T Lyman,&nbsp;K A Frankel","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The program at Donner Pavilion has applied nuclear medicine research to the diagnosis and radiosurgical treatment of life-threatening intracranial vascular disorders that affect approximately one million Americans. Stereotactic heavy-ion Bragg peak radiosurgery, using narrow beams of heavy ions (helium), demonstrates superior biological and physical characteristics in brain over X and gamma rays and protons, viz., improved dose distribution in the Bragg peak, sharp lateral and distal borders, and less multiple scattering and range straggling for the same residual range in CNS tissue. Examination of CNS tissue response and alteration of cerebral blood-flow dynamics related to heavy-ion Bragg peak radiosurgery is being undertaken using three-dimensional treatment planning and quantitative imaging utilizing cerebral angiography, computerized tomography (CT), magnetic resonance imaging (MRI), cine-CT, xenon X-ray CT, and positron emission tomography (PET). Also under examination are the physical properties of narrow heavy-ion beams for improving methods of dose delivery and dose distribution and for establishing clinical RBE/LET and dose-response relationships for human CNS tissues. Based on the evaluation and treatment with stereotactically directed narrow beams of heavy ions of over 130 patients, with cerebral angiography and CT scanning, and with MRI and radioisotope scanning of selected patients, plus extensive clinical and neuroradiological follow-up, it appears that heavy-ion radiosurgery obliterates intracranial arteriovenous malformations or protects against rebleeding with reduced morbidity and mortality.</p>","PeriodicalId":77888,"journal":{"name":"Radiation research. Supplement","volume":"8 ","pages":"S244-58"},"PeriodicalIF":0.0,"publicationDate":"1985-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"15051969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Potential for low-LET charged-particle radiation therapy in cancer. 低let带电粒子放射治疗癌症的潜力。
Pub Date : 1985-01-01
M Goitein, H D Suit, E Gragoudas, A M Koehler, R Wilson

The current and likely future status of low-LET charged-particle therapy of cancer is reviewed with regard to both physical and clinical aspects. We conclude that such therapy has reached the stage at which clinical implementation is practical and that a broader program is needed if the clinical advantages of improved dose distributions are to be determined.

从物理和临床两方面综述了低let电荷粒子治疗癌症的现状和可能的未来状况。我们的结论是,这种疗法已达到临床实施的阶段,如果要确定改善剂量分布的临床优势,则需要更广泛的计划。
{"title":"Potential for low-LET charged-particle radiation therapy in cancer.","authors":"M Goitein,&nbsp;H D Suit,&nbsp;E Gragoudas,&nbsp;A M Koehler,&nbsp;R Wilson","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The current and likely future status of low-LET charged-particle therapy of cancer is reviewed with regard to both physical and clinical aspects. We conclude that such therapy has reached the stage at which clinical implementation is practical and that a broader program is needed if the clinical advantages of improved dose distributions are to be determined.</p>","PeriodicalId":77888,"journal":{"name":"Radiation research. Supplement","volume":"8 ","pages":"S297-309"},"PeriodicalIF":0.0,"publicationDate":"1985-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"15053557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preparatory clinical studies of Pi-mesons at TRIUMF. π介子在TRIUMF的预备临床研究。
Pub Date : 1985-01-01 DOI: 10.2307/3583538
G. Goodman, P. Dixon, G. Lam, R. Harrison, R. Kornelsen, C. Ludgate, A. Flores
Eighty patients have been treated with Pi-mesons (pions) at TRIUMF between 1979-1984. The patients had tumors rarely curable by standard methods and had no prior radiotherapy. The distribution by site included skin, metastatic nodules (13), brain, glioblastoma multiforme (32), pelvis, rectosigmoid (15), prostate (12), bladder (7), and ovary (1). The studies involve serial escalations of pion dose until maximum tissue tolerance is reached, monitoring the response at each dose increment. Sites were chosen for study where lack of local control is a significant cause of treatment failure with conventional radiation therapy. The low dose rate and the available beam access at TRIUMF limit the number of patients treated and the volume treatable. A 3-D treatment planning program is in use, and a 3-D display of the dose distribution delivered in brain tumor treatments has been developed using the PET scanner. In practice, new methods introduced for measurement of tissue response include tumor growth delay curves, fine-needle biopsy mapping, and PET scanning of brain tumors. The use of endoscopic assessment of the rectosigmoid region is emphasized. Treatment results of glioblastoma multiforme show that the median survival for patients treated to 125 pion cGy/fx is in the range of 187-198 days; for patients receiving 170 cGy per dose/fraction (fx) the range is 290-315 days, and for those receiving 200-220 cGy/fx the median survival is in excess of 290 days. For pelvic malignancies the local control obtained with doses of 2500 cGy or less was 50% in 12 assessable patients; it was 75% in 20 patients who had 3000 cGy or more.(ABSTRACT TRUNCATED AT 250 WORDS)
1979-1984年间,在TRIUMF有80名患者接受了π介子(π介子)治疗。这些患者的肿瘤很难用标准方法治愈,并且之前没有接受过放疗。按部位分布包括皮肤、转移性结节(13例)、脑、多形胶质母细胞瘤(32例)、骨盆、乙状直肠(15例)、前列腺(12例)、膀胱(7例)和卵巢(1例)。研究包括连续增加介子剂量,直到达到最大组织耐受性,监测每次剂量增加的反应。研究选择的地点缺乏局部控制是传统放射治疗失败的重要原因。低剂量率和在TRIUMF的可用光束通道限制了治疗的患者数量和可治疗的体积。3-D治疗计划程序正在使用中,并且使用PET扫描仪开发了脑肿瘤治疗中剂量分布的3-D显示。在实践中,引入了测量组织反应的新方法,包括肿瘤生长延迟曲线,细针活检绘图和脑肿瘤的PET扫描。强调使用内窥镜评估直肠乙状结肠区域。多形性胶质母细胞瘤的治疗结果显示,治疗至125介子cGy/fx的患者中位生存期为187-198天;对于每剂量/分数(fx)接受170 cGy治疗的患者,生存期为290-315天,而对于接受200-220 cGy/fx治疗的患者,中位生存期超过290天。对于盆腔恶性肿瘤,在12例可评估的患者中,2500 cGy或更低剂量获得的局部控制率为50%;在20名患者中有75%的人摄入了3000 cGy或更多。(摘要删节250字)
{"title":"Preparatory clinical studies of Pi-mesons at TRIUMF.","authors":"G. Goodman, P. Dixon, G. Lam, R. Harrison, R. Kornelsen, C. Ludgate, A. Flores","doi":"10.2307/3583538","DOIUrl":"https://doi.org/10.2307/3583538","url":null,"abstract":"Eighty patients have been treated with Pi-mesons (pions) at TRIUMF between 1979-1984. The patients had tumors rarely curable by standard methods and had no prior radiotherapy. The distribution by site included skin, metastatic nodules (13), brain, glioblastoma multiforme (32), pelvis, rectosigmoid (15), prostate (12), bladder (7), and ovary (1). The studies involve serial escalations of pion dose until maximum tissue tolerance is reached, monitoring the response at each dose increment. Sites were chosen for study where lack of local control is a significant cause of treatment failure with conventional radiation therapy. The low dose rate and the available beam access at TRIUMF limit the number of patients treated and the volume treatable. A 3-D treatment planning program is in use, and a 3-D display of the dose distribution delivered in brain tumor treatments has been developed using the PET scanner. In practice, new methods introduced for measurement of tissue response include tumor growth delay curves, fine-needle biopsy mapping, and PET scanning of brain tumors. The use of endoscopic assessment of the rectosigmoid region is emphasized. Treatment results of glioblastoma multiforme show that the median survival for patients treated to 125 pion cGy/fx is in the range of 187-198 days; for patients receiving 170 cGy per dose/fraction (fx) the range is 290-315 days, and for those receiving 200-220 cGy/fx the median survival is in excess of 290 days. For pelvic malignancies the local control obtained with doses of 2500 cGy or less was 50% in 12 assessable patients; it was 75% in 20 patients who had 3000 cGy or more.(ABSTRACT TRUNCATED AT 250 WORDS)","PeriodicalId":77888,"journal":{"name":"Radiation research. Supplement","volume":"40 1","pages":"S279-84"},"PeriodicalIF":0.0,"publicationDate":"1985-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77470098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
High-LET radiation carcinogenesis. 高let辐射致癌作用。
Pub Date : 1985-01-01 DOI: 10.2307/3576646
R. Fry, P. Powers-Risius, E. Alpen, E. J. Ainsworth
The dose-response curves for the induction of tumors by high-LET radiation are complex and are insufficiently understood. There is no model or formulation to describe the dose-response relationship over a range 0-100 rad. Evidence suggests that at doses below 20 rad the response is linear, at least for life shortening and some tumor systems. Thus limiting values of RBEs for the induction of cancer in various tissues can be determined, but it will require sufficient data obtained at low single doses or with small fractions. The results obtained from experiments with heavy ions indicate an initial linear response with a plateauing of the curve at a tumor incidence level that is dependent on the type of tissue. The RBE values for the heavy ions using 60Co gamma rays as the reference radiation increase with the estimated LET from 4 or 4H to about 27 for 56Fe and 40Ar. The dose responses and RBEs for 56Fe and 40Ar are similar to those for fission neutrons. These findings suggest the possibility that the effectiveness for tumor induction reaches a maximum.
高let辐射诱导肿瘤的剂量-反应曲线是复杂的,并没有得到充分的了解。没有模型或公式来描述0-100 rad范围内的剂量-反应关系。有证据表明,在低于20 rad的剂量下,至少对于缩短寿命和某些肿瘤系统而言,反应是线性的。因此,可以确定RBEs在各种组织中诱导癌症的限制值,但这将需要在低单剂量或小组分下获得足够的数据。从重离子实验中获得的结果表明,在肿瘤发生率水平上,曲线的初始线性响应与稳定,这取决于组织的类型。以60Co伽马射线作为参考辐射的重离子的RBE值随着估计LET从4或4H增加到56Fe和40Ar的约27。56Fe和40Ar的剂量响应和rbe与裂变中子相似。这些发现提示其诱导肿瘤的有效性可能达到最大值。
{"title":"High-LET radiation carcinogenesis.","authors":"R. Fry, P. Powers-Risius, E. Alpen, E. J. Ainsworth","doi":"10.2307/3576646","DOIUrl":"https://doi.org/10.2307/3576646","url":null,"abstract":"The dose-response curves for the induction of tumors by high-LET radiation are complex and are insufficiently understood. There is no model or formulation to describe the dose-response relationship over a range 0-100 rad. Evidence suggests that at doses below 20 rad the response is linear, at least for life shortening and some tumor systems. Thus limiting values of RBEs for the induction of cancer in various tissues can be determined, but it will require sufficient data obtained at low single doses or with small fractions. The results obtained from experiments with heavy ions indicate an initial linear response with a plateauing of the curve at a tumor incidence level that is dependent on the type of tissue. The RBE values for the heavy ions using 60Co gamma rays as the reference radiation increase with the estimated LET from 4 or 4H to about 27 for 56Fe and 40Ar. The dose responses and RBEs for 56Fe and 40Ar are similar to those for fission neutrons. These findings suggest the possibility that the effectiveness for tumor induction reaches a maximum.","PeriodicalId":77888,"journal":{"name":"Radiation research. Supplement","volume":"8 1","pages":"S188-95"},"PeriodicalIF":0.0,"publicationDate":"1985-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82495107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 129
In vitro and in vivo studies of the TRIUMF pion therapy beam. TRIUMF介子治疗束的体外和体内研究。
Pub Date : 1985-01-01 DOI: 10.2307/3583520
L. Skarsgard, B. Douglas, J. Denekamp, D. Chaplin, G. Lam, R. Harrison, R. Kornelsen, B. Palcic
Patient treatments at TRIUMF (Tri-University Meson Facility, Vancouver, B. C.) use a moving spot raster scan technique where the pion range is modulated in depth for each position of the moving spot. The spot scans in a stepwise fashion and can produce any desired field shape. This approach provides very good dose uniformity across the treatment field and allows maximum flexibility in shaping the treatment volume. Survival of cultured cells has been used as a biological dosimeter to test the isoeffectiveness of the pion dose distributions, which must be shaped in depth to compensate for the depth-dependent LET distribution. Isoeffectiveness across the treatment field has also been verified using this system, which involves irradiating cells supported in a gelatin matrix. The response of pig skin to pion irradiation at TRIUMF has provided a check on the in vivo RBE for acute effects derived from our earlier studies with mouse foot. In addition, the pig skin reactions have been followed for several months to assess the later dermal response. The RBE of our pion beam relative to 270 kVp X rays is approximately 1.5 for both the acute epidermal and the later dermal responses.
在TRIUMF(三大学介子设施,温哥华,不列颠哥伦比亚省)的病人治疗使用移动点光栅扫描技术,其中介子范围在移动点的每个位置进行深度调制。点扫描在一个逐步的方式,可以产生任何所需的场形状。这种方法在整个治疗领域提供了非常好的剂量均匀性,并允许在塑造治疗体积方面具有最大的灵活性。培养细胞的存活已被用作生物剂量计来测试介子剂量分布的等效性,介子剂量分布必须在深度上形成,以补偿深度依赖的LET分布。使用该系统也验证了整个治疗领域的等效性,该系统涉及到在明胶基质中支持的照射细胞。在TRIUMF,猪皮对介子辐照的反应为我们早期小鼠足的急性效应提供了体内RBE的检查。此外,对猪的皮肤反应进行了几个月的随访,以评估后期的皮肤反应。对于急性表皮反应和后期皮肤反应,我们的介子光束相对于270 kVp X射线的RBE约为1.5。
{"title":"In vitro and in vivo studies of the TRIUMF pion therapy beam.","authors":"L. Skarsgard, B. Douglas, J. Denekamp, D. Chaplin, G. Lam, R. Harrison, R. Kornelsen, B. Palcic","doi":"10.2307/3583520","DOIUrl":"https://doi.org/10.2307/3583520","url":null,"abstract":"Patient treatments at TRIUMF (Tri-University Meson Facility, Vancouver, B. C.) use a moving spot raster scan technique where the pion range is modulated in depth for each position of the moving spot. The spot scans in a stepwise fashion and can produce any desired field shape. This approach provides very good dose uniformity across the treatment field and allows maximum flexibility in shaping the treatment volume. Survival of cultured cells has been used as a biological dosimeter to test the isoeffectiveness of the pion dose distributions, which must be shaped in depth to compensate for the depth-dependent LET distribution. Isoeffectiveness across the treatment field has also been verified using this system, which involves irradiating cells supported in a gelatin matrix. The response of pig skin to pion irradiation at TRIUMF has provided a check on the in vivo RBE for acute effects derived from our earlier studies with mouse foot. In addition, the pig skin reactions have been followed for several months to assess the later dermal response. The RBE of our pion beam relative to 270 kVp X rays is approximately 1.5 for both the acute epidermal and the later dermal responses.","PeriodicalId":77888,"journal":{"name":"Radiation research. Supplement","volume":"74 1","pages":"S135-44"},"PeriodicalIF":0.0,"publicationDate":"1985-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80643547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Calculation of heavy-ion tracks in liquid water. 液态水重离子径迹的计算。
Pub Date : 1985-01-01
R N Hamm, J E Turner, R H Ritchie, H A Wright

Detailed Monte Carlo calculations are presented of proton and alpha-particle tracks in liquid water. The computations treat the interactions of the primary particle and all secondary electrons on a statistical, event-by-event basis to simulate the initial physical changes that accompany the passage of an ion through water. Our methods for obtaining the cross sections needed for such calculations are described. Inelastic scattering probabilities (inverse mean free paths) are derived from a complex dielectric response function constructed for liquid water, based on experimental and theoretical data. Examples of partial cross sections for ionization and excitation by protons are shown. The computation of electron transport and energy loss includes exchange, elastic scattering, and a scheme for the delocalization of energy shared collectively by a large number of electrons in the condensed medium. Several examples of calculated proton and alpha-particle tracks are presented and discussed. The meaning and significance of the concept of a track core are briefly addressed in the light of this work. The present paper treats only the initial, physical changes produced by radiation in water (in approximately 10(-15) s in local regions of a track). The work described here is used in calculations that we have reported in other publications on the later chemical development of charged-particle tracks.

给出了液态水中质子和粒子轨迹的详细蒙特卡罗计算。计算处理的主要粒子和所有次级电子的相互作用,在一个事件一个事件的基础上,模拟最初的物理变化,伴随着一个离子通过水。本文描述了我们获得这种计算所需的截面的方法。基于实验和理论数据,推导了液态水的复介电响应函数的非弹性散射概率(平均自由程逆)。给出了质子电离和激发的部分截面的例子。电子输运和能量损失的计算包括交换、弹性散射和一种在凝聚介质中由大量电子共同分享的能量的离域方案。给出并讨论了几个计算出的质子和粒子轨迹的例子。结合本工作,简要论述了轨道核概念的意义和意义。本文只讨论辐射在水中产生的初始物理变化(在轨道的局部区域大约10(-15)秒)。这里描述的工作用于我们在其他出版物中报道的关于后来带电粒子轨迹的化学发展的计算。
{"title":"Calculation of heavy-ion tracks in liquid water.","authors":"R N Hamm,&nbsp;J E Turner,&nbsp;R H Ritchie,&nbsp;H A Wright","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Detailed Monte Carlo calculations are presented of proton and alpha-particle tracks in liquid water. The computations treat the interactions of the primary particle and all secondary electrons on a statistical, event-by-event basis to simulate the initial physical changes that accompany the passage of an ion through water. Our methods for obtaining the cross sections needed for such calculations are described. Inelastic scattering probabilities (inverse mean free paths) are derived from a complex dielectric response function constructed for liquid water, based on experimental and theoretical data. Examples of partial cross sections for ionization and excitation by protons are shown. The computation of electron transport and energy loss includes exchange, elastic scattering, and a scheme for the delocalization of energy shared collectively by a large number of electrons in the condensed medium. Several examples of calculated proton and alpha-particle tracks are presented and discussed. The meaning and significance of the concept of a track core are briefly addressed in the light of this work. The present paper treats only the initial, physical changes produced by radiation in water (in approximately 10(-15) s in local regions of a track). The work described here is used in calculations that we have reported in other publications on the later chemical development of charged-particle tracks.</p>","PeriodicalId":77888,"journal":{"name":"Radiation research. Supplement","volume":"8 ","pages":"S20-6"},"PeriodicalIF":0.0,"publicationDate":"1985-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14137023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Radiation research. Supplement
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1